mTORC1 and DNA‐PKcs as novel molecular determinants of sensitivity to Chk1 inhibition
Andrew J. Massey(Granta Design (United Kingdom)), Nicola J. Curtin(Newcastle University)
Cited by 24
Related Papers
Chk1 Inhibition as a novel therapeutic strategy for treating triple-negative breast and ovarian cancers
|BMC Cancer|2014|110
Inhibition of the checkpoint kinase Chk1 induces DNA damage and cell death in human Leukemia and Lymphoma cells
|Molecular Cancer|2014|53
Multiparametric Cell Cycle Analysis Using the Operetta High-Content Imager and Harmony Software with PhenoLOGIC
|PLoS ONE|2015|46